ELITE PHARMACEUTICALS's ticker is ELTP and the CUSIP is 28659T200. A total of 2 filers reported holding ELITE PHARMACEUTICALS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,693 | +223.5% | 82,000 | 0.0% | 0.00% | – |
| Q1 2023 | $2,378 | -20.7% | 82,000 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 82,000 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | +33.3% | 82,000 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 82,000 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | – | 82,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FISHMAN JAY A LTD/MI | 60,000 | $10,560,000 | 0.00% |
| Geneva Advisors, LLC | 293,180 | $52,000 | 0.00% |
| Sargent Bickham Lagudis LLC | 40,000 | $7,000 | 0.00% |
| Personal Capital Advisors Corp | 25,000 | $4,000 | 0.00% |
| VALLEY WEALTH MANAGERS, INC. | 7,500 | $1,000 | 0.00% |